Despite policy uncertainties in recent years, WuXi Biologics’ emphasis on its U.S. operations continued to pay off in 2025, with the States accounting for a major portion of the record number of projects the CRDMO locked in last year.
WuXi Bio’s record number of new projects in 2025 leaned heavily on US clients
Latest from Blog
Loneliness, Isolation Can Strip Away Years Of Healthy Life, Large Study Finds
Post Content Post Views: 2
Stroke Rates Nearly Double In Younger Adults
Post Content Post Views: 2
Federal judge rolls back landmark disability protections
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Chelsea Cirruzzo filling in here today from D.C., where another fox has
How The MIND Diet Protects Aging Brains
Post Content Post Views: 2
Keeping A Steady Job Might Help You Stay Sharp Later In Life
Post Content Post Views: 2